United States · Bill · HR
H.R. 1298 (107th)
Orphan Drug Tax Credit Act of 2001
Introduced
29 March 2001
Last action
—
Status
Referred to the House Committee on Ways and Means.
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2025
Summary
Orphan Drug Tax Credit Act of 2001 - Amends the Internal Revenue Code to move up the date for which a taxpayer may claim the credit for the clinical testing of drugs for rare diseases or conditions (orphan drugs) from the date a drug is designated an orphan drug to the date the application for such designation is filed.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 29 March 2001
Introduced in House (PDF)
Introduced in House · EN · 29 March 2001
Introduced in House
summary · EN · 29 March 2001
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/1298
- Open data entity: https://api.congress.gov/v3/bill/107/hr/1298